{"nct_id":"NCT00219232","title":"An Open-label Extension to Evaluate the Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease","status":"COMPLETED","status_verified_date":"2017-02","start_date":"2003-02","start_date_type":null,"primary_completion_date":"2006-07","primary_completion_date_type":"ACTUAL","completion_date":"2006-07","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}